Debio 1450

DRUG3 trials

Sponsors

Debiopharm International SA

Conditions

Bacterial InfectionsBone Diseases, InfectiousHealthy Participants

Phase 1

A Single Dose Study of Debio 1450 in Healthy Subjects

CompletedNCT02162199

Debiopharm International SABacterial Infections

Start: 2014-06-30End: 2014-10-31Updated: 2014-10-23

Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery

CompletedNCT02726438

Debiopharm International SABone Diseases, Infectious

Start: 2016-04-30End: 2017-06-30Updated: 2017-10-18

A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects

CompletedNCT03209648

Debiopharm International SAHealthy Participants

Start: 2017-06-14End: 2017-08-31Updated: 2017-10-18

Related Papers

Bone and Joint Tissue Penetration of the <i>Staphylococcus</i>-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery.

2019-02-2621 citations